Contineum Therapeutics Grants Stock Options to New Employee Under Inducement Plan
I'm PortAI, I can summarize articles.
Contineum Therapeutics Inc. has granted a non-qualified stock option for 23,000 shares of Class A common stock to a new non-executive employee. The option vests over four years, with 25% vesting after one year and the rest monthly over 36 months. The exercise price matches the closing price on the grant date, and the option has a ten-year term. This grant is part of the company’s 2026 Employment Inducement Equity Incentive Plan.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments